Recursion Pharmaceuticals, Inc. (RXRX)
 NASDAQ: RXRX · Real-Time Price · USD
 5.65
 -0.22 (-3.75%)
  At close: Oct 30, 2025, 4:00 PM EDT
5.70
 +0.05 (0.88%)
  After-hours: Oct 30, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $19.22M in the quarter ending June 30, 2025, with 33.34% growth. This brings the company's revenue in the last twelve months to $64.60M, up 30.14% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm) 
 $64.60M
Revenue Growth 
 +30.14%
P/S Ratio 
 31.47
Revenue / Employee 
 $80,745
Employees 
 800
Market Cap 
2.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 58.84M | 14.26M | 32.00% | 
| Dec 31, 2023 | 44.58M | 4.73M | 11.88% | 
| Dec 31, 2022 | 39.84M | 29.67M | 291.46% | 
| Dec 31, 2021 | 10.18M | 6.22M | 156.89% | 
| Dec 31, 2020 | 3.96M | 1.64M | 70.85% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 63.62B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 55.19B | 
| Eli Lilly and Company | 53.26B | 
| Novo Nordisk | 49.11B | 
RXRX News
- 2 days ago - Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th - GlobeNewsWire
- 8 days ago - Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks - Benzinga
- 22 days ago - What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
- 7 weeks ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 2 months ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Recursion Pharmaceuticals, Inc. (RXRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire